2017-03-23,Outcomes Data From Over 950 Severe Burn Patients Treated With Epicel Presented At The 49th Annual Meeting Of The American Burn Association
2017-03-10,Vericel Reports Fourth-Quarter And Year-End 2016 Financial Results
2017-03-03,Vericel To Host Fourth-Quarter 2016 Earnings Webcast And Conference Call On March 10, 2017
2017-02-27,Vericel To Present At Multiple Upcoming Investor Conferences
2017-02-21,Vericel Receives FDA Fast Track Designation For Ixmyelocel-T, An Investigational Product For The Treatment Of Patients With Advanced Heart Failure Due To Ischemic Dilated Cardiomyopathy
2017-02-01,Vericel Announces First MACI Implant In The United States For The Treatment Of Symptomatic Cartilage Defects Of The Knee
2017-01-24,First Week of VCEL March 17th Options Trading
2016-12-21,Vericel Corporation Announces Exercise Of Underwriters' Over-Allotment Option And Closing Of $20 Million Offering Of Common Stock
2016-12-16,Vericel Corporation Prices $17 Million Public Offering Of Common Stock
2016-12-15,Vericel Corporation Announces Proposed Public Offering Of Common Stock
2016-12-14,FDA Approves MACI For The Treatment Of Symptomatic Cartilage Defects Of The Knee In Adults
2016-11-22,Vericel To Present At 28th Annual Piper Jaffray Healthcare Conference
2016-11-14,Additional Pre-Specified Secondary Results On The Reduction Of Ventricular Arrhythmias Presented At AHA From Vericel's Positive Phase 2b IxCELL-DCM Clinical Trial Of Ixmyelocel-T
2016-11-07,Vericel Reports Third-Quarter 2016 Financial Results
2016-10-31,Vericel To Host Third-Quarter 2016 Earnings Webcast And Conference Call On November 7, 2016
2016-09-26,Vericel To Present At 2016 Cell & Gene Meeting On The Mesa
2016-09-21,Vericel To Present At Ladenburg Thalmann Healthcare Conference
2016-09-12,Vericel Enters Into Expanded $20 Million Credit Facility And Term Loan With Silicon Valley Bank And MidCap Financial Services
2016-09-07,Vericel To Present Data At The American Heart Association's Scientific Sessions 2016 On The Reduction Of Ventricular Arrhythmias With Ixmyelocel-T In The IxCELL-DCM Clinical Trial
2016-08-08,Vericel Reports Second-Quarter 2016 Financial Results
2016-08-01,Vericel To Host Second-Quarter 2016 Earnings Webcast And Conference Call On August 8, 2016
2016-07-06,Vericel To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference
2016-05-10,Vericel Reports First-Quarter 2016 Financial Results
2016-04-27,Vericel To Host First-Quarter 2016 Earnings Webcast And Conference Call On May 10, 2016
2016-04-08,Vericel To Present At 15th Annual Needham Healthcare Conference
2016-04-06,Strong On High Volume: Vericel (VCEL)
2016-04-05,Vericel (VCEL) Is Weak On High Volume Today
2016-04-04,Results From Vericel's Positive Phase 2b IxCELL-DCM Clinical Trial Of Ixmyelocel-T Presented Today At ACC And Published In The Lancet
2016-03-29,Vericel To Host Review Of Positive Phase 2b IxCELL-DCM Trial Results Following American College Of Cardiology 65th Annual Scientific Sessions
2016-03-28,Trade-Ideas: Vericel (VCEL) Is Today's "Perilous Reversal" Stock
2016-03-28,Vericel Announces Publication Of Clinical Trial Rationale And Study Design For The Phase 2b IxCELL-DCM Trial Of Ixmyelocel-T In Patients With Heart Failure Due To Ischemic Dilated Cardiomyopathy
2016-03-22,Interesting VCEL Put And Call Options For May 20th
2016-03-22,Vericel (VCEL) Flagged As Strong On High Volume
2016-03-15,Vericel (VCEL) Flagged As Strong On High Volume
2016-03-14,Vericel (VCEL) Stock Falling on Q4 Results
2016-03-14,Trade-Ideas: Vericel (VCEL) Is Today's "Perilous Reversal" Stock
2016-03-14,Vericel Reports Fourth-Quarter And Year-End 2015 Financial Results
2016-03-11,Vericel (VCEL) Is Today's Pre-Market Mover With Heavy Volume Stock
2016-03-10,Vericel (VCEL) Stock Soars on Positive Phase 2 Trial Results
2016-03-10,Vericel Announces Positive Top-Line Results From Phase 2b IxCELL-DCM Clinical Trial Of Ixmyelocel-T In Patients With Heart Failure Due To Ischemic Dilated Cardiomyopathy
2016-03-09,Vericel Enters Into $10 Million Credit Facility And $5 Million Term Loan Agreement With Silicon Valley Bank
2016-03-08,Vericel To Present At 28th Annual ROTH Conference
2016-03-07,Vericel Announces FDA Acceptance For Filing Of BLA For MACI For The Treatment Of Symptomatic Cartilage Defects In The Knee
2016-02-26,Vericel To Host Fourth-Quarter 2015 Earnings Webcast And Conference Call On March 14, 2016
2016-02-24,Vericel To Present At Canaccord Genuity Investor Conference
2016-02-22,Vericel Announces FDA Approval Of Epicel HDE Supplement
2016-01-04,Vericel Submits Biologics License Application To The FDA For MACI For The Treatment Of Cartilage Defects In The Knee
2015-12-08,Vericel Submits HDE Supplement To The FDA To Revise The Labeled Indications For Use And Add Pediatric Labeling For Epicel
2015-11-13,Vericel Reports Third-Quarter 2015 Financial Results
2015-11-03,Vericel To Host Third-Quarter 2015 Earnings Webcast And Conference Call On November 13, 2015
2015-09-23,Vericel To Present At Upcoming Investor Conferences
2015-08-12,Vericel Reports Second-Quarter 2015 Financial Results
2015-07-29,Vericel To Host Second-Quarter 2015 Earnings Webcast And Conference Call On August 12, 2015
2015-07-14,Vericel Announces Plan To Submit HDE Supplement To The FDA To Revise The Labeled Indications For Use And Add Pediatric Labeling For Epicel
2015-06-10,Vericel Announces Plan To Submit Biologics License Application To FDA By Year-End 2015 For MACI For The Treatment Of Cartilage Defects In The Knee
2015-05-14,Vericel Reports First-Quarter 2015 Financial Results
2015-04-30,Vericel To Host First-Quarter 2015 Earnings Webcast And Conference Call On May 14, 2015
2015-04-08,Vericel To Present At Needham Healthcare Conference
2015-03-25,Vericel Reports Three-Year Follow-Up Results From Phase 3 SUMMIT Extension Study Of MACI(TM) Implant
2015-03-24,Vericel (VCEL) Stock Gains Today on Better Than Expected Quarter
2015-03-23,Vericel Reports Fourth-Quarter And Year-End 2014 Financial Results
2015-03-18,Vericel To Present At Canaccord Genuity And ARM Investor Conferences
2015-03-12,Vericel To Host Fourth-Quarter 2014 Earnings Call On March 23, 2015
2015-03-06,Vericel To Present At 27th Annual ROTH Conference
2015-01-29,Vericel Completes Patient Enrollment In Phase 2b IxCELL-DCM Clinical Study Of Ixmyelocel-T
,
,
,
